Search research articles
Contact Us
Filters
Showing results (221-230 of 425) with videos related to
Page
of 43
Sort By:
Current Pharmaceutical Design
|
February 1, 2018
Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases
Rosaria Vincenza Giglio, Angelo Maria Patti, Arrigo F G Cicero, et al.
Atherosclerosis
|
October 10, 2014
Combination therapy in dyslipidemia: where are we now?
Alberico L Catapano, Michel Farnier, JoAnne M Foody, et al.
Clinical Cardiology
|
June 24, 2015
Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia
Rajeshwari S Punekar, Kathleen M Fox, Akshara Richhariya, et al.
Current Pharmaceutical Design
|
March 21, 2017
Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia
Angelo M Patti, Peter P Toth, Rosaria V Giglio, et al.
American Journal of Preventive Cardiology
|
November 25, 2022
Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology
Charles A German, Seth J Baum, Keith C Ferdinand, et al.
Journal of Clinical Lipidology
|
April 9, 2018
Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial
Peter P Toth, Steven R Jones, April Slee, et al.
Current Medical Research and Opinion
|
March 10, 2017
Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study
Rajeshwari S Punekar, Kathleen M Fox, Carly J Paoli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
April 1, 2017
Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review
Santosh K Padala, Michael P Lavelle, Mandeep S Sidhu, et al.
Vascular Health and Risk Management
|
December 31, 2010
Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
William Insull, Peter P Toth, H Robert Superko, et al.
JAMA
|
November 19, 2013
Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile
Seth S Martin, Michael J Blaha, Mohamed B Elshazly, et al.
Page
of 43
Search research articles
Search
Showing results (221-230 of 425) with videos related to
Sort By:
Page
of 43
Current Pharmaceutical Design
|
February 1, 2018
Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases
Rosaria Vincenza Giglio, Angelo Maria Patti, Arrigo F G Cicero, et al.
Atherosclerosis
|
October 10, 2014
Combination therapy in dyslipidemia: where are we now?
Alberico L Catapano, Michel Farnier, JoAnne M Foody, et al.
Clinical Cardiology
|
June 24, 2015
Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia
Rajeshwari S Punekar, Kathleen M Fox, Akshara Richhariya, et al.
Current Pharmaceutical Design
|
March 21, 2017
Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia
Angelo M Patti, Peter P Toth, Rosaria V Giglio, et al.
American Journal of Preventive Cardiology
|
November 25, 2022
Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology
Charles A German, Seth J Baum, Keith C Ferdinand, et al.
Journal of Clinical Lipidology
|
April 9, 2018
Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial
Peter P Toth, Steven R Jones, April Slee, et al.
Current Medical Research and Opinion
|
March 10, 2017
Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study
Rajeshwari S Punekar, Kathleen M Fox, Carly J Paoli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
April 1, 2017
Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review
Santosh K Padala, Michael P Lavelle, Mandeep S Sidhu, et al.
Vascular Health and Risk Management
|
December 31, 2010
Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
William Insull, Peter P Toth, H Robert Superko, et al.
JAMA
|
November 19, 2013
Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile
Seth S Martin, Michael J Blaha, Mohamed B Elshazly, et al.
Page
of 43